Edgewise Therapeutics EWTX
NASDAQ EWTX
$45.96 -2.78 (-5.71%)
As of: Nov 10, 2026 · 3:20 PM EST

Edgewise Therapeutics (EWTX) Share-based Compensation (IS) (2025 - 2026)

Updated

Analysis

Edgewise Therapeutics (EWTX) Share-based Compensation (IS) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Edgewise Therapeutics 5.00 Bn 2.24 Bn - 8.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 8.57 Mn
Sep 30, 2025 8.09 Mn
API Access

Edgewise Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=EWTX&period=max&api_key=YOUR_API_KEY